Stocks · News reference
Galmed Pharmaceuticals Announces Rebrand To Eocene And Nasdaq Ticker Change From GLMD To EOCN Effective September 10; Announces Termination Of Yorkville Standby Equity Purchase Agreement Effective September 8
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Galmed Pharmaceuticals shares are trading higher after the company's subsidiary Colospan announced the completion of a feasibility study supporting the development of a novel intraoperative colon tissue quality assessment platform.
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times